These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7484215)

  • 1. Hydroxy- and non-hydroxy-galactolipids in developing rat CNS.
    De Haas CG; Lopes-Cardozo M
    Int J Dev Neurosci; 1995 Aug; 13(5):447-54. PubMed ID: 7484215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead exposure affects levels of galactolipid metabolic enzymes in the developing rat brain.
    Deng W; Poretz RD
    Toxicol Appl Pharmacol; 2001 Apr; 172(2):98-107. PubMed ID: 11298496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive hypoxia inhibits the de novo synthesis of galactosylceramide in cultured oligodendrocytes.
    Kendler A; Dawson G
    J Biol Chem; 1990 Jul; 265(21):12259-66. PubMed ID: 2115515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of brefeldin A on galactosphingolipid synthesis in an immortalized Schwann cell line: evidence for different intracellular locations of galactosylceramide sulfotransferase and ceramide galactosyltransferase activities.
    Farrer RG; Warden MP; Quarles RH
    J Neurochem; 1995 Oct; 65(4):1865-73. PubMed ID: 7561886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in nervous system glycolipids during metamorphosis of Xenopus laevis.
    Okamura N; Kishimoto Y
    J Biol Chem; 1983 Oct; 258(20):12243-6. PubMed ID: 6630186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin.
    Maldonado EN; Alderson NL; Monje PV; Wood PM; Hama H
    J Lipid Res; 2008 Jan; 49(1):153-61. PubMed ID: 17901466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
    Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
    BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
    Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
    J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and transport of cerebrosides and sulfatides in rat brain during development.
    Koul O; Singh I; Jungalwala FB
    J Neurochem; 1988 Feb; 50(2):580-8. PubMed ID: 3121793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalent cation-mediated interaction between cerebroside sulfate and cerebrosides: an investigation of the effect of structural variations of lipids by electrospray ionization mass spectrometry.
    Koshy KM; Wang J; Boggs JM
    Biophys J; 1999 Jul; 77(1):306-18. PubMed ID: 10388759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane glycolipids and human immunodeficiency virus infection of primary macrophages.
    Seddiki N; Ben Younes-Chennoufi A; Benjouad A; Saffar L; Baumann N; Gluckman JC; Gattegno L
    AIDS Res Hum Retroviruses; 1996 May; 12(8):695-703. PubMed ID: 8744580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactosylceramide sulfotransferase, arylsulfatase A and cerebroside sulfatase activity in different regions of developing rat brain.
    van der Pal RH; Klein W; van Golde LM; Lopes-Cardozo M
    Biochim Biophys Acta; 1990 Mar; 1043(1):91-6. PubMed ID: 1968763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide.
    Dasgupta S; Levery SB; Hogan EL
    J Lipid Res; 2002 May; 43(5):751-61. PubMed ID: 11971946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfatide species with various fatty acid chains in oligodendrocytes at different developmental stages determined by imaging mass spectrometry.
    Hirahara Y; Wakabayashi T; Mori T; Koike T; Yao I; Tsuda M; Honke K; Gotoh H; Ono K; Yamada H
    J Neurochem; 2017 Feb; 140(3):435-450. PubMed ID: 27861899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of galactolipid elimination on oligodendrocyte development and myelination.
    Marcus J; Dupree JL; Popko B
    Glia; 2000 Jun; 30(4):319-28. PubMed ID: 10797612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of non-hydroxy-galactosylceramides and galactosyldiglycerides by hydroxy-ceramide galactosyltransferase.
    van der Bijl P; Strous GJ; Lopes-Cardozo M; Thomas-Oates J; van Meer G
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):589-97. PubMed ID: 8713090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic phases of galactocerebrosides: spectroscopic evidence of lamellar crystalline structures.
    Bou Khalil M; Carrier D; Wong PT; Tanphaichitr N
    Biochim Biophys Acta; 2001 Jun; 1512(2):158-70. PubMed ID: 11406093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin galactolipid synthesis in different strains of mice.
    Sato C; Yu RK
    J Neurochem; 1987 Oct; 49(4):1069-74. PubMed ID: 3625200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
    Coetzee T; Dupree JL; Popko B
    J Neurosci Res; 1998 Dec; 54(5):613-22. PubMed ID: 9843152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.